Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial

University of Groningen

Correction to

Smith-Apeldoorn, Sanne Y; Veraart, Jolien K E; Kamphuis, Jeanine; van Asselt, Antoinette D

I; Touw, Daan J; Aan Het Rot, Marije; Schoevers, Robert A

Published in:

BMC Psychiatry

DOI:

10.1186/s12888-019-2398-7

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Smith-Apeldoorn, S. Y., Veraart, J. K. E., Kamphuis, J., van Asselt, A. D. I., Touw, D. J., Aan Het Rot, M., &

Schoevers, R. A. (2020). Correction to: Oral esketamine for treatment-resistant depression: rationale and

design of a randomized controlled trial. BMC Psychiatry, 20(1), [9].

https://doi.org/10.1186/s12888-019-2398-7

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

CO RR EC T ION

Open Access

Correction to: Oral esketamine for

treatment-resistant depression: rationale

and design of a randomized controlled trial

Sanne Y. Smith-Apeldoorn

, Jolien K. E. Veraart

, Jeanine Kamphuis

, Antoinette D. I. van Asselt

, Daan J. Touw

,

Marije aan het Rot

and Robert A. Schoevers

Correction to: BMC Psychiatry (2019) 19:375

https://doi.org/10.1186/s12888-019-2359-1

After publication of our article [

1

] we were notified

that Fig.

1

was wrongly presented.

The correct figure and corresponding title is presented

below:

The original article has been corrected.

1_{Department of Psychiatry, University of Groningen, University Medical}

Center Groningen, PO box 30.0001, 9700, RB, Groningen, The Netherlands.

2_{Department of Psychiatry, PsyQ Haaglanden, Parnassia Psychiatric Institute,}

The Hague, The Netherlands.3_{Department of Epidemiology, University of}

Groningen, University Medical Center Groningen, Groningen, The

Netherlands.4_{Department of Clinical Pharmacy and Pharmacology, University}

of Groningen, University Medical Center Groningen, Groningen, The Netherlands.5_{Department of Psychology, University of Groningen,}

Groningen, The Netherlands.

Reference

1. Smith-Apeldoorn SY, et al. Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial. BMC Psychiatry. 2019;19:375.https://doi.org/10.1186/s12888-019-2359-1.

© The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

The original article can be found online at https://doi.org/10.1186/s12888-019-2359-1

* Correspondence:s.y.apeldoorn@umcg.nl

1_{Department of Psychiatry, University of Groningen, University Medical}

Center Groningen, PO box 30.0001, 9700, RB, Groningen, The Netherlands Full list of author information is available at the end of the article

Fig. 1 Trial flowchart. Schematic overview of the study design. T: Number illustrates number of weeks after baseline

Smith-Apeldoornet al. BMC Psychiatry (2020) 20:9 https://doi.org/10.1186/s12888-019-2398-7